SciELO - Scientific Electronic Library Online

 
vol.24 issue4Rhupus syndrome. A rare combinationMale patient with C1q nephropathy and rheumatoid arthritis: A case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

RINCON-RIANO, Diana Nathalie; FERNANDEZ-AVILA, Daniel G.  and  GUTIERREZ, Juan M.. Leflunomide-induced Stevens Johnson syndrome in a patient with systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2017, vol.24, n.4, pp.242-246. ISSN 0121-8123.

Leflunomide is an immunomodulatory agent widely used in rheumatoid arthritis and other rheumatic diseases like psoriatic arthritis and systemic lupus erythematosus. Although its safety profile is generally good, side effects have been reported in up to 20% of cases. Severe reactions, such as toxic epidermal necrolysis and Stevens Johnson syndrome are rare. The case is presented of a leflunomide-induced Stevens Johnson syndrome in a patient with systemic lupus erythematosus.

Keywords : Leflunomide; Stevens-Johnson syndrome; Adverse effects.

        · abstract in Spanish     · text in English     · English ( pdf )